Oncogene - Table of Contents alert Volume 30 Issue 43

TABLE OF CONTENTS Volume 30, Issue 43 (October 2011) In this issue Review Original Articles Short Communication Also new AOP Advertisment The World Cancer Metabolism Summit translates the revival of Warburg into commercial drug development. The agenda designed specifically for drug developers, with experts at GSK, AstraZeneca, Genentech, Myrexis, Cornerstone and Warburg Glycomed. Seize your chance to take part in the fast growing community which is translating the Warburg phenomenon into a new generation of cancer therapies. Register Now Download the Brochure Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement NATURE REVIEWS CANCER TURNS 10 Nature Reviews Cancer celebrates its 10 year anniversary with a specially commissioned Article Series that explores today's hottest research areas such as epigenetics, heterogeneity and metastasis, as well as forward looking concepts that could result in new treatments for cancer patients. Read the October Anniversary Issue online: www.nature.com/nrc Read the Article Series online: www.nature.com/nrc/series/thenext10   Review Top Integrin-linked kinase: Not so ‘pseudo’ after all G E Hannigan, P C McDonald, M P Walsh and S Dedhar Oncogene 2011 30: 4375-4385; advance online publication, May 23, 2011; 10.1038/onc.2011.177 Abstract | Full Text Original Articles Top miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo A Holleman, I Chung, R R Olsen, B Kwak, A Mizokami, N Saijo, A Parissenti, Z Duan, E E Voest and B R Zetter Oncogene 2011 30: 4386-4398; advance online publication, May 9, 2011; 10.1038/onc.2011.148 Abstract | Full Text Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer W Bu, J Chen, G D Morrison, S Huang, C J Creighton, J Huang, G C Chamness, S G Hilsenbeck, D R Roop, A D Leavitt and Y Li Oncogene 2011 30: 4399-4409; advance online publication, May 2, 2011; 10.1038/onc.2011.147 Abstract | Full Text HAb18G/CD147 promotes epithelial–mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug J Wu, N-Y Ru, Y Zhang, Y Li, D Wei, Z Ren, X-F Huang, Z-N Chen and H Bian Oncogene 2011 30: 4410-4427; advance online publication, May 2, 2011; 10.1038/onc.2011.149 Abstract | Full Text Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice F Nitzki, A Zibat, A Frommhold, A Schneider, W Schulz-Schaeffer, T Braun and H Hahn Oncogene 2011 30: 4428-4436; advance online publication, May 23, 2011; 10.1038/onc.2011.157 Abstract | Full Text FZD7 has a critical role in cell proliferation in triple negative breast cancer L Yang, X Wu, Y Wang, K Zhang, J Wu, Y-C Yuan, X Deng, L Chen, C C H Kim, S Lau, G Somlo and Y Yen Oncogene 2011 30: 4437-4446; advance online publication, May 2, 2011; 10.1038/onc.2011.145 Abstract | Full Text Short Communication Top Targeting fibroblast growth factor receptor 3 enhances radiosensitivity in human squamous cancer cells K Uzawa, T Ishigami, K Fushimi, T Kawata, K Shinozuka, A Kasamatsu, Y Sakamoto, K Ogawara, M Shiiba, H Bukawa, H Ito and H Tanzawa Oncogene 2011 30: 4447-4452; advance online publication, May 16, 2011; 10.1038/onc.2011.159 Abstract | Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.